ResApp Completes Successful Pre-Submission Meeting with the US FDA
Mar 14, 2016 18:49 pm UTC| Business
PERTH, Western Australia, March 14, 2016 -- ResApp Health Limited (ASX:RAP), announced today a positive outcome from its recent Pre-Submission Meeting with the United States Food and Drug Administration (FDA) regarding...
SigmaTron International, Inc. Reports Third Quarter Financial Results for Fiscal 2016
Mar 14, 2016 18:30 pm UTC| Business
ELK GROVE VILLAGE, Ill., March 14, 2016 -- SigmaTron International, Inc. (NASDAQ:SGMA), an electronic manufacturing services company, today reported revenues and earnings for the third quarter ended January 31, 2016. ...
GeneNews Limited Announces Private Placement Financing of up to $5 Million
Mar 14, 2016 18:27 pm UTC| Business
TORONTO, March 14, 2016 -- GeneNews Limited (“GeneNews” or the “Company”) (TSX:GEN) today announced that it is undertaking a non-brokered private placement of up to 50,000,000 common shares of the Company at a price of...
Commonwealth Equipment Leasing Funds to Disclose NAV in April
Mar 14, 2016 18:17 pm UTC| Business
TAMPA, Fla., March 14, 2016 -- Commonwealth Capital Corp., through its general partner and manager, has engaged an accredited valuation firm to determine the net asset values for units in all public and private...
DEINOVE and ARBIOM join forces to develop a "carbon-free" chemical industry
Mar 14, 2016 18:06 pm UTC| Business
The two companies have started a collaboration to demonstrate the synergy of their respective technologies for the valorization of non-food plant biomass. In an initial phase, DEINOVE tested its technology on wood...
Redding Bank of Commerce Finalizes Acquisition of Five Branch Locations
Mar 14, 2016 17:52 pm UTC| Business
REDDING, Calif., March 14, 2016 -- Bank of Commerce Holdings (NASDAQ:BOCH) (the “Company”), a $1 billion asset bank holding company and parent company of Redding Bank of Commerce (the “Bank”), today announced that the...
Mar 14, 2016 17:40 pm UTC| Business
MENLO PARK, Calif., March 14, 2016 -- Versartis, Inc. (NASDAQ:VSAR), an endocrine-focused biopharmaceutical company that is developing somavaratan (VRS-317), a novel, long-acting form of recombinant human growth hormone...